nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertraline—SIGMAR1—Tamoxifen—pancreatic cancer	0.178	0.253	CbGbCtD
Sertraline—CYP2B6—Tamoxifen—pancreatic cancer	0.0481	0.0683	CbGbCtD
Sertraline—CYP2B6—Irinotecan—pancreatic cancer	0.0369	0.0524	CbGbCtD
Sertraline—CYP1A2—Dacarbazine—pancreatic cancer	0.0354	0.0503	CbGbCtD
Sertraline—CYP2C19—Tamoxifen—pancreatic cancer	0.0305	0.0434	CbGbCtD
Sertraline—CYP1A2—Tamoxifen—pancreatic cancer	0.0282	0.04	CbGbCtD
Sertraline—CYP2C9—Tamoxifen—pancreatic cancer	0.0254	0.0361	CbGbCtD
Sertraline—ABCB1—Tamoxifen—pancreatic cancer	0.0246	0.035	CbGbCtD
Sertraline—CYP1A2—Erlotinib—pancreatic cancer	0.024	0.034	CbGbCtD
Sertraline—CYP2D6—Tamoxifen—pancreatic cancer	0.0232	0.033	CbGbCtD
Sertraline—ABCB1—Gemcitabine—pancreatic cancer	0.0212	0.0302	CbGbCtD
Sertraline—ABCB1—Erlotinib—pancreatic cancer	0.021	0.0298	CbGbCtD
Sertraline—CYP1A2—Fluorouracil—pancreatic cancer	0.0208	0.0295	CbGbCtD
Sertraline—CYP2B6—Doxorubicin—pancreatic cancer	0.0202	0.0286	CbGbCtD
Sertraline—CYP2D6—Erlotinib—pancreatic cancer	0.0197	0.0281	CbGbCtD
Sertraline—ABCB1—Irinotecan—pancreatic cancer	0.0189	0.0269	CbGbCtD
Sertraline—CYP2C9—Fluorouracil—pancreatic cancer	0.0187	0.0266	CbGbCtD
Sertraline—CYP3A4—Tamoxifen—pancreatic cancer	0.0148	0.021	CbGbCtD
Sertraline—ABCB1—Docetaxel—pancreatic cancer	0.0139	0.0197	CbGbCtD
Sertraline—ABCB1—Sunitinib—pancreatic cancer	0.0138	0.0196	CbGbCtD
Sertraline—CYP3A4—Erlotinib—pancreatic cancer	0.0126	0.0178	CbGbCtD
Sertraline—CYP3A4—Irinotecan—pancreatic cancer	0.0113	0.0161	CbGbCtD
Sertraline—ABCB1—Doxorubicin—pancreatic cancer	0.0103	0.0147	CbGbCtD
Sertraline—CYP2D6—Doxorubicin—pancreatic cancer	0.00974	0.0138	CbGbCtD
Sertraline—CYP3A4—Docetaxel—pancreatic cancer	0.00831	0.0118	CbGbCtD
Sertraline—CYP3A4—Sunitinib—pancreatic cancer	0.00827	0.0118	CbGbCtD
Sertraline—CYP3A4—Doxorubicin—pancreatic cancer	0.00619	0.0088	CbGbCtD
Sertraline—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000107	0.000362	CcSEcCtD
Sertraline—Oedema—Docetaxel—pancreatic cancer	0.000107	0.000362	CcSEcCtD
Sertraline—Weight increased—Doxorubicin—pancreatic cancer	0.000107	0.000362	CcSEcCtD
Sertraline—Epistaxis—Epirubicin—pancreatic cancer	0.000107	0.000361	CcSEcCtD
Sertraline—Pruritus—Gemcitabine—pancreatic cancer	0.000107	0.000361	CcSEcCtD
Sertraline—Weight decreased—Doxorubicin—pancreatic cancer	0.000107	0.00036	CcSEcCtD
Sertraline—Sinusitis—Epirubicin—pancreatic cancer	0.000106	0.00036	CcSEcCtD
Sertraline—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000106	0.000359	CcSEcCtD
Sertraline—Diarrhoea—Irinotecan—pancreatic cancer	0.000106	0.000359	CcSEcCtD
Sertraline—Agranulocytosis—Epirubicin—pancreatic cancer	0.000106	0.000358	CcSEcCtD
Sertraline—Shock—Docetaxel—pancreatic cancer	0.000106	0.000357	CcSEcCtD
Sertraline—Nervous system disorder—Docetaxel—pancreatic cancer	0.000105	0.000355	CcSEcCtD
Sertraline—Pruritus—Fluorouracil—pancreatic cancer	0.000105	0.000355	CcSEcCtD
Sertraline—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000105	0.000355	CcSEcCtD
Sertraline—Drowsiness—Doxorubicin—pancreatic cancer	0.000105	0.000355	CcSEcCtD
Sertraline—Tachycardia—Docetaxel—pancreatic cancer	0.000105	0.000354	CcSEcCtD
Sertraline—Skin disorder—Docetaxel—pancreatic cancer	0.000104	0.000352	CcSEcCtD
Sertraline—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000104	0.000352	CcSEcCtD
Sertraline—Bradycardia—Epirubicin—pancreatic cancer	0.000104	0.00035	CcSEcCtD
Sertraline—Diarrhoea—Gemcitabine—pancreatic cancer	0.000103	0.000349	CcSEcCtD
Sertraline—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000103	0.000348	CcSEcCtD
Sertraline—Dizziness—Irinotecan—pancreatic cancer	0.000103	0.000347	CcSEcCtD
Sertraline—Haemoglobin—Epirubicin—pancreatic cancer	0.000102	0.000346	CcSEcCtD
Sertraline—Stomatitis—Doxorubicin—pancreatic cancer	0.000102	0.000346	CcSEcCtD
Sertraline—Jaundice—Doxorubicin—pancreatic cancer	0.000102	0.000346	CcSEcCtD
Sertraline—Anorexia—Docetaxel—pancreatic cancer	0.000102	0.000345	CcSEcCtD
Sertraline—Rhinitis—Epirubicin—pancreatic cancer	0.000102	0.000345	CcSEcCtD
Sertraline—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000102	0.000345	CcSEcCtD
Sertraline—Haemorrhage—Epirubicin—pancreatic cancer	0.000102	0.000344	CcSEcCtD
Sertraline—Hepatitis—Epirubicin—pancreatic cancer	0.000102	0.000344	CcSEcCtD
Sertraline—Diarrhoea—Fluorouracil—pancreatic cancer	0.000102	0.000344	CcSEcCtD
Sertraline—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000101	0.000342	CcSEcCtD
Sertraline—Pharyngitis—Epirubicin—pancreatic cancer	0.000101	0.000341	CcSEcCtD
Sertraline—Sweating—Doxorubicin—pancreatic cancer	0.000101	0.00034	CcSEcCtD
Sertraline—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000101	0.00034	CcSEcCtD
Sertraline—Oedema peripheral—Epirubicin—pancreatic cancer	0.0001	0.000339	CcSEcCtD
Sertraline—Hypotension—Docetaxel—pancreatic cancer	0.0001	0.000339	CcSEcCtD
Sertraline—Haematuria—Doxorubicin—pancreatic cancer	0.0001	0.000338	CcSEcCtD
Sertraline—Connective tissue disorder—Epirubicin—pancreatic cancer	0.0001	0.000338	CcSEcCtD
Sertraline—Urethral disorder—Epirubicin—pancreatic cancer	9.98e-05	0.000337	CcSEcCtD
Sertraline—Hepatobiliary disease—Doxorubicin—pancreatic cancer	9.93e-05	0.000335	CcSEcCtD
Sertraline—Epistaxis—Doxorubicin—pancreatic cancer	9.9e-05	0.000334	CcSEcCtD
Sertraline—Vomiting—Irinotecan—pancreatic cancer	9.87e-05	0.000333	CcSEcCtD
Sertraline—Sinusitis—Doxorubicin—pancreatic cancer	9.85e-05	0.000333	CcSEcCtD
Sertraline—Dizziness—Fluorouracil—pancreatic cancer	9.83e-05	0.000332	CcSEcCtD
Sertraline—Visual impairment—Epirubicin—pancreatic cancer	9.82e-05	0.000332	CcSEcCtD
Sertraline—Agranulocytosis—Doxorubicin—pancreatic cancer	9.8e-05	0.000331	CcSEcCtD
Sertraline—Rash—Irinotecan—pancreatic cancer	9.79e-05	0.000331	CcSEcCtD
Sertraline—Dermatitis—Irinotecan—pancreatic cancer	9.78e-05	0.00033	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	9.77e-05	0.00033	CcSEcCtD
Sertraline—Headache—Irinotecan—pancreatic cancer	9.72e-05	0.000328	CcSEcCtD
Sertraline—Insomnia—Docetaxel—pancreatic cancer	9.7e-05	0.000328	CcSEcCtD
Sertraline—Paraesthesia—Docetaxel—pancreatic cancer	9.63e-05	0.000325	CcSEcCtD
Sertraline—Erythema multiforme—Epirubicin—pancreatic cancer	9.63e-05	0.000325	CcSEcCtD
Sertraline—Vomiting—Gemcitabine—pancreatic cancer	9.61e-05	0.000325	CcSEcCtD
Sertraline—Bradycardia—Doxorubicin—pancreatic cancer	9.59e-05	0.000324	CcSEcCtD
Sertraline—Dyspnoea—Docetaxel—pancreatic cancer	9.56e-05	0.000323	CcSEcCtD
Sertraline—Somnolence—Docetaxel—pancreatic cancer	9.54e-05	0.000322	CcSEcCtD
Sertraline—Rash—Gemcitabine—pancreatic cancer	9.53e-05	0.000322	CcSEcCtD
Sertraline—Dermatitis—Gemcitabine—pancreatic cancer	9.52e-05	0.000322	CcSEcCtD
Sertraline—Eye disorder—Epirubicin—pancreatic cancer	9.52e-05	0.000322	CcSEcCtD
Sertraline—Tinnitus—Epirubicin—pancreatic cancer	9.5e-05	0.000321	CcSEcCtD
Sertraline—Haemoglobin—Doxorubicin—pancreatic cancer	9.47e-05	0.00032	CcSEcCtD
Sertraline—Headache—Gemcitabine—pancreatic cancer	9.47e-05	0.00032	CcSEcCtD
Sertraline—Cardiac disorder—Epirubicin—pancreatic cancer	9.45e-05	0.000319	CcSEcCtD
Sertraline—Flushing—Epirubicin—pancreatic cancer	9.45e-05	0.000319	CcSEcCtD
Sertraline—Vomiting—Fluorouracil—pancreatic cancer	9.45e-05	0.000319	CcSEcCtD
Sertraline—Rhinitis—Doxorubicin—pancreatic cancer	9.45e-05	0.000319	CcSEcCtD
Sertraline—Dyspepsia—Docetaxel—pancreatic cancer	9.44e-05	0.000319	CcSEcCtD
Sertraline—Haemorrhage—Doxorubicin—pancreatic cancer	9.42e-05	0.000318	CcSEcCtD
Sertraline—Hepatitis—Doxorubicin—pancreatic cancer	9.42e-05	0.000318	CcSEcCtD
Sertraline—Hypoaesthesia—Doxorubicin—pancreatic cancer	9.38e-05	0.000317	CcSEcCtD
Sertraline—Rash—Fluorouracil—pancreatic cancer	9.37e-05	0.000317	CcSEcCtD
Sertraline—Dermatitis—Fluorouracil—pancreatic cancer	9.36e-05	0.000316	CcSEcCtD
Sertraline—Pharyngitis—Doxorubicin—pancreatic cancer	9.35e-05	0.000316	CcSEcCtD
Sertraline—Decreased appetite—Docetaxel—pancreatic cancer	9.33e-05	0.000315	CcSEcCtD
Sertraline—Headache—Fluorouracil—pancreatic cancer	9.31e-05	0.000315	CcSEcCtD
Sertraline—Urinary tract disorder—Doxorubicin—pancreatic cancer	9.31e-05	0.000314	CcSEcCtD
Sertraline—Oedema peripheral—Doxorubicin—pancreatic cancer	9.28e-05	0.000314	CcSEcCtD
Sertraline—Gastrointestinal disorder—Docetaxel—pancreatic cancer	9.26e-05	0.000313	CcSEcCtD
Sertraline—Connective tissue disorder—Doxorubicin—pancreatic cancer	9.26e-05	0.000313	CcSEcCtD
Sertraline—Fatigue—Docetaxel—pancreatic cancer	9.25e-05	0.000312	CcSEcCtD
Sertraline—Angiopathy—Epirubicin—pancreatic cancer	9.24e-05	0.000312	CcSEcCtD
Sertraline—Urethral disorder—Doxorubicin—pancreatic cancer	9.24e-05	0.000312	CcSEcCtD
Sertraline—Nausea—Irinotecan—pancreatic cancer	9.22e-05	0.000311	CcSEcCtD
Sertraline—Immune system disorder—Epirubicin—pancreatic cancer	9.2e-05	0.000311	CcSEcCtD
Sertraline—Mediastinal disorder—Epirubicin—pancreatic cancer	9.18e-05	0.00031	CcSEcCtD
Sertraline—Pain—Docetaxel—pancreatic cancer	9.17e-05	0.00031	CcSEcCtD
Sertraline—Constipation—Docetaxel—pancreatic cancer	9.17e-05	0.00031	CcSEcCtD
Sertraline—Chills—Epirubicin—pancreatic cancer	9.14e-05	0.000309	CcSEcCtD
Sertraline—Arrhythmia—Epirubicin—pancreatic cancer	9.1e-05	0.000307	CcSEcCtD
Sertraline—Visual impairment—Doxorubicin—pancreatic cancer	9.08e-05	0.000307	CcSEcCtD
Sertraline—Alopecia—Epirubicin—pancreatic cancer	9e-05	0.000304	CcSEcCtD
Sertraline—Nausea—Gemcitabine—pancreatic cancer	8.98e-05	0.000303	CcSEcCtD
Sertraline—Mental disorder—Epirubicin—pancreatic cancer	8.92e-05	0.000301	CcSEcCtD
Sertraline—Erythema multiforme—Doxorubicin—pancreatic cancer	8.91e-05	0.000301	CcSEcCtD
Sertraline—Erythema—Epirubicin—pancreatic cancer	8.87e-05	0.000299	CcSEcCtD
Sertraline—Malnutrition—Epirubicin—pancreatic cancer	8.87e-05	0.000299	CcSEcCtD
Sertraline—Feeling abnormal—Docetaxel—pancreatic cancer	8.84e-05	0.000299	CcSEcCtD
Sertraline—Nausea—Fluorouracil—pancreatic cancer	8.83e-05	0.000298	CcSEcCtD
Sertraline—Eye disorder—Doxorubicin—pancreatic cancer	8.81e-05	0.000297	CcSEcCtD
Sertraline—Tinnitus—Doxorubicin—pancreatic cancer	8.79e-05	0.000297	CcSEcCtD
Sertraline—Gastrointestinal pain—Docetaxel—pancreatic cancer	8.77e-05	0.000296	CcSEcCtD
Sertraline—Cardiac disorder—Doxorubicin—pancreatic cancer	8.75e-05	0.000295	CcSEcCtD
Sertraline—Flushing—Doxorubicin—pancreatic cancer	8.75e-05	0.000295	CcSEcCtD
Sertraline—Flatulence—Epirubicin—pancreatic cancer	8.74e-05	0.000295	CcSEcCtD
Sertraline—Tension—Epirubicin—pancreatic cancer	8.7e-05	0.000294	CcSEcCtD
Sertraline—Dysgeusia—Epirubicin—pancreatic cancer	8.68e-05	0.000293	CcSEcCtD
Sertraline—Nervousness—Epirubicin—pancreatic cancer	8.61e-05	0.000291	CcSEcCtD
Sertraline—Back pain—Epirubicin—pancreatic cancer	8.58e-05	0.00029	CcSEcCtD
Sertraline—Angiopathy—Doxorubicin—pancreatic cancer	8.55e-05	0.000289	CcSEcCtD
Sertraline—Muscle spasms—Epirubicin—pancreatic cancer	8.52e-05	0.000288	CcSEcCtD
Sertraline—Immune system disorder—Doxorubicin—pancreatic cancer	8.51e-05	0.000288	CcSEcCtD
Sertraline—Mediastinal disorder—Doxorubicin—pancreatic cancer	8.49e-05	0.000287	CcSEcCtD
Sertraline—Abdominal pain—Docetaxel—pancreatic cancer	8.48e-05	0.000286	CcSEcCtD
Sertraline—Body temperature increased—Docetaxel—pancreatic cancer	8.48e-05	0.000286	CcSEcCtD
Sertraline—Chills—Doxorubicin—pancreatic cancer	8.46e-05	0.000286	CcSEcCtD
Sertraline—Arrhythmia—Doxorubicin—pancreatic cancer	8.42e-05	0.000284	CcSEcCtD
Sertraline—Alopecia—Doxorubicin—pancreatic cancer	8.33e-05	0.000281	CcSEcCtD
Sertraline—Mental disorder—Doxorubicin—pancreatic cancer	8.26e-05	0.000279	CcSEcCtD
Sertraline—Ill-defined disorder—Epirubicin—pancreatic cancer	8.23e-05	0.000278	CcSEcCtD
Sertraline—Erythema—Doxorubicin—pancreatic cancer	8.2e-05	0.000277	CcSEcCtD
Sertraline—Malnutrition—Doxorubicin—pancreatic cancer	8.2e-05	0.000277	CcSEcCtD
Sertraline—Anaemia—Epirubicin—pancreatic cancer	8.2e-05	0.000277	CcSEcCtD
Sertraline—Agitation—Epirubicin—pancreatic cancer	8.15e-05	0.000275	CcSEcCtD
Sertraline—Flatulence—Doxorubicin—pancreatic cancer	8.08e-05	0.000273	CcSEcCtD
Sertraline—Tension—Doxorubicin—pancreatic cancer	8.05e-05	0.000272	CcSEcCtD
Sertraline—Dysgeusia—Doxorubicin—pancreatic cancer	8.03e-05	0.000271	CcSEcCtD
Sertraline—Malaise—Epirubicin—pancreatic cancer	8e-05	0.00027	CcSEcCtD
Sertraline—Nervousness—Doxorubicin—pancreatic cancer	7.97e-05	0.000269	CcSEcCtD
Sertraline—Vertigo—Epirubicin—pancreatic cancer	7.97e-05	0.000269	CcSEcCtD
Sertraline—Syncope—Epirubicin—pancreatic cancer	7.95e-05	0.000269	CcSEcCtD
Sertraline—Leukopenia—Epirubicin—pancreatic cancer	7.94e-05	0.000268	CcSEcCtD
Sertraline—Back pain—Doxorubicin—pancreatic cancer	7.94e-05	0.000268	CcSEcCtD
Sertraline—Hypersensitivity—Docetaxel—pancreatic cancer	7.9e-05	0.000267	CcSEcCtD
Sertraline—Muscle spasms—Doxorubicin—pancreatic cancer	7.89e-05	0.000266	CcSEcCtD
Sertraline—Palpitations—Epirubicin—pancreatic cancer	7.84e-05	0.000265	CcSEcCtD
Sertraline—Loss of consciousness—Epirubicin—pancreatic cancer	7.79e-05	0.000263	CcSEcCtD
Sertraline—Cough—Epirubicin—pancreatic cancer	7.74e-05	0.000261	CcSEcCtD
Sertraline—Asthenia—Docetaxel—pancreatic cancer	7.7e-05	0.00026	CcSEcCtD
Sertraline—Convulsion—Epirubicin—pancreatic cancer	7.68e-05	0.000259	CcSEcCtD
Sertraline—Hypertension—Epirubicin—pancreatic cancer	7.66e-05	0.000259	CcSEcCtD
Sertraline—Ill-defined disorder—Doxorubicin—pancreatic cancer	7.61e-05	0.000257	CcSEcCtD
Sertraline—Pruritus—Docetaxel—pancreatic cancer	7.59e-05	0.000256	CcSEcCtD
Sertraline—Anaemia—Doxorubicin—pancreatic cancer	7.58e-05	0.000256	CcSEcCtD
Sertraline—Chest pain—Epirubicin—pancreatic cancer	7.55e-05	0.000255	CcSEcCtD
Sertraline—Arthralgia—Epirubicin—pancreatic cancer	7.55e-05	0.000255	CcSEcCtD
Sertraline—Myalgia—Epirubicin—pancreatic cancer	7.55e-05	0.000255	CcSEcCtD
Sertraline—Agitation—Doxorubicin—pancreatic cancer	7.54e-05	0.000255	CcSEcCtD
Sertraline—Anxiety—Epirubicin—pancreatic cancer	7.52e-05	0.000254	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	7.5e-05	0.000253	CcSEcCtD
Sertraline—Discomfort—Epirubicin—pancreatic cancer	7.46e-05	0.000252	CcSEcCtD
Sertraline—Malaise—Doxorubicin—pancreatic cancer	7.4e-05	0.00025	CcSEcCtD
Sertraline—Dry mouth—Epirubicin—pancreatic cancer	7.38e-05	0.000249	CcSEcCtD
Sertraline—Vertigo—Doxorubicin—pancreatic cancer	7.37e-05	0.000249	CcSEcCtD
Sertraline—Syncope—Doxorubicin—pancreatic cancer	7.36e-05	0.000248	CcSEcCtD
Sertraline—Leukopenia—Doxorubicin—pancreatic cancer	7.34e-05	0.000248	CcSEcCtD
Sertraline—Diarrhoea—Docetaxel—pancreatic cancer	7.34e-05	0.000248	CcSEcCtD
Sertraline—Confusional state—Epirubicin—pancreatic cancer	7.3e-05	0.000246	CcSEcCtD
Sertraline—Palpitations—Doxorubicin—pancreatic cancer	7.25e-05	0.000245	CcSEcCtD
Sertraline—Oedema—Epirubicin—pancreatic cancer	7.24e-05	0.000244	CcSEcCtD
Sertraline—Anaphylactic shock—Epirubicin—pancreatic cancer	7.24e-05	0.000244	CcSEcCtD
Sertraline—Loss of consciousness—Doxorubicin—pancreatic cancer	7.21e-05	0.000244	CcSEcCtD
Sertraline—Cough—Doxorubicin—pancreatic cancer	7.16e-05	0.000242	CcSEcCtD
Sertraline—Shock—Epirubicin—pancreatic cancer	7.12e-05	0.00024	CcSEcCtD
Sertraline—Convulsion—Doxorubicin—pancreatic cancer	7.11e-05	0.00024	CcSEcCtD
Sertraline—Nervous system disorder—Epirubicin—pancreatic cancer	7.1e-05	0.00024	CcSEcCtD
Sertraline—Dizziness—Docetaxel—pancreatic cancer	7.09e-05	0.00024	CcSEcCtD
Sertraline—Thrombocytopenia—Epirubicin—pancreatic cancer	7.09e-05	0.000239	CcSEcCtD
Sertraline—Hypertension—Doxorubicin—pancreatic cancer	7.08e-05	0.000239	CcSEcCtD
Sertraline—Tachycardia—Epirubicin—pancreatic cancer	7.06e-05	0.000239	CcSEcCtD
Sertraline—Skin disorder—Epirubicin—pancreatic cancer	7.03e-05	0.000237	CcSEcCtD
Sertraline—Hyperhidrosis—Epirubicin—pancreatic cancer	7e-05	0.000236	CcSEcCtD
Sertraline—Arthralgia—Doxorubicin—pancreatic cancer	6.98e-05	0.000236	CcSEcCtD
Sertraline—Myalgia—Doxorubicin—pancreatic cancer	6.98e-05	0.000236	CcSEcCtD
Sertraline—Chest pain—Doxorubicin—pancreatic cancer	6.98e-05	0.000236	CcSEcCtD
Sertraline—Anxiety—Doxorubicin—pancreatic cancer	6.96e-05	0.000235	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	6.94e-05	0.000234	CcSEcCtD
Sertraline—Discomfort—Doxorubicin—pancreatic cancer	6.9e-05	0.000233	CcSEcCtD
Sertraline—Anorexia—Epirubicin—pancreatic cancer	6.9e-05	0.000233	CcSEcCtD
Sertraline—Dry mouth—Doxorubicin—pancreatic cancer	6.83e-05	0.000231	CcSEcCtD
Sertraline—Vomiting—Docetaxel—pancreatic cancer	6.82e-05	0.00023	CcSEcCtD
Sertraline—Rash—Docetaxel—pancreatic cancer	6.76e-05	0.000228	CcSEcCtD
Sertraline—Hypotension—Epirubicin—pancreatic cancer	6.76e-05	0.000228	CcSEcCtD
Sertraline—Dermatitis—Docetaxel—pancreatic cancer	6.76e-05	0.000228	CcSEcCtD
Sertraline—Confusional state—Doxorubicin—pancreatic cancer	6.75e-05	0.000228	CcSEcCtD
Sertraline—Headache—Docetaxel—pancreatic cancer	6.72e-05	0.000227	CcSEcCtD
Sertraline—Anaphylactic shock—Doxorubicin—pancreatic cancer	6.7e-05	0.000226	CcSEcCtD
Sertraline—Oedema—Doxorubicin—pancreatic cancer	6.7e-05	0.000226	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	6.59e-05	0.000223	CcSEcCtD
Sertraline—Shock—Doxorubicin—pancreatic cancer	6.59e-05	0.000222	CcSEcCtD
Sertraline—Nervous system disorder—Doxorubicin—pancreatic cancer	6.57e-05	0.000222	CcSEcCtD
Sertraline—Thrombocytopenia—Doxorubicin—pancreatic cancer	6.56e-05	0.000221	CcSEcCtD
Sertraline—Insomnia—Epirubicin—pancreatic cancer	6.54e-05	0.000221	CcSEcCtD
Sertraline—Tachycardia—Doxorubicin—pancreatic cancer	6.53e-05	0.000221	CcSEcCtD
Sertraline—Skin disorder—Doxorubicin—pancreatic cancer	6.5e-05	0.00022	CcSEcCtD
Sertraline—Paraesthesia—Epirubicin—pancreatic cancer	6.5e-05	0.000219	CcSEcCtD
Sertraline—Hyperhidrosis—Doxorubicin—pancreatic cancer	6.47e-05	0.000219	CcSEcCtD
Sertraline—Dyspnoea—Epirubicin—pancreatic cancer	6.45e-05	0.000218	CcSEcCtD
Sertraline—Somnolence—Epirubicin—pancreatic cancer	6.43e-05	0.000217	CcSEcCtD
Sertraline—Anorexia—Doxorubicin—pancreatic cancer	6.38e-05	0.000216	CcSEcCtD
Sertraline—Nausea—Docetaxel—pancreatic cancer	6.37e-05	0.000215	CcSEcCtD
Sertraline—Dyspepsia—Epirubicin—pancreatic cancer	6.37e-05	0.000215	CcSEcCtD
Sertraline—Decreased appetite—Epirubicin—pancreatic cancer	6.29e-05	0.000212	CcSEcCtD
Sertraline—Hypotension—Doxorubicin—pancreatic cancer	6.26e-05	0.000211	CcSEcCtD
Sertraline—Gastrointestinal disorder—Epirubicin—pancreatic cancer	6.25e-05	0.000211	CcSEcCtD
Sertraline—Fatigue—Epirubicin—pancreatic cancer	6.24e-05	0.000211	CcSEcCtD
Sertraline—Pain—Epirubicin—pancreatic cancer	6.19e-05	0.000209	CcSEcCtD
Sertraline—Constipation—Epirubicin—pancreatic cancer	6.19e-05	0.000209	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	6.1e-05	0.000206	CcSEcCtD
Sertraline—Insomnia—Doxorubicin—pancreatic cancer	6.06e-05	0.000205	CcSEcCtD
Sertraline—Paraesthesia—Doxorubicin—pancreatic cancer	6.01e-05	0.000203	CcSEcCtD
Sertraline—Dyspnoea—Doxorubicin—pancreatic cancer	5.97e-05	0.000202	CcSEcCtD
Sertraline—Feeling abnormal—Epirubicin—pancreatic cancer	5.96e-05	0.000201	CcSEcCtD
Sertraline—Somnolence—Doxorubicin—pancreatic cancer	5.95e-05	0.000201	CcSEcCtD
Sertraline—Gastrointestinal pain—Epirubicin—pancreatic cancer	5.92e-05	0.0002	CcSEcCtD
Sertraline—Dyspepsia—Doxorubicin—pancreatic cancer	5.89e-05	0.000199	CcSEcCtD
Sertraline—Decreased appetite—Doxorubicin—pancreatic cancer	5.82e-05	0.000197	CcSEcCtD
Sertraline—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	5.78e-05	0.000195	CcSEcCtD
Sertraline—Fatigue—Doxorubicin—pancreatic cancer	5.77e-05	0.000195	CcSEcCtD
Sertraline—Urticaria—Epirubicin—pancreatic cancer	5.75e-05	0.000194	CcSEcCtD
Sertraline—Pain—Doxorubicin—pancreatic cancer	5.73e-05	0.000193	CcSEcCtD
Sertraline—Constipation—Doxorubicin—pancreatic cancer	5.73e-05	0.000193	CcSEcCtD
Sertraline—Abdominal pain—Epirubicin—pancreatic cancer	5.72e-05	0.000193	CcSEcCtD
Sertraline—Body temperature increased—Epirubicin—pancreatic cancer	5.72e-05	0.000193	CcSEcCtD
Sertraline—Feeling abnormal—Doxorubicin—pancreatic cancer	5.52e-05	0.000186	CcSEcCtD
Sertraline—Gastrointestinal pain—Doxorubicin—pancreatic cancer	5.48e-05	0.000185	CcSEcCtD
Sertraline—Hypersensitivity—Epirubicin—pancreatic cancer	5.33e-05	0.00018	CcSEcCtD
Sertraline—Urticaria—Doxorubicin—pancreatic cancer	5.32e-05	0.00018	CcSEcCtD
Sertraline—Body temperature increased—Doxorubicin—pancreatic cancer	5.29e-05	0.000179	CcSEcCtD
Sertraline—Abdominal pain—Doxorubicin—pancreatic cancer	5.29e-05	0.000179	CcSEcCtD
Sertraline—Asthenia—Epirubicin—pancreatic cancer	5.19e-05	0.000175	CcSEcCtD
Sertraline—Pruritus—Epirubicin—pancreatic cancer	5.12e-05	0.000173	CcSEcCtD
Sertraline—Diarrhoea—Epirubicin—pancreatic cancer	4.95e-05	0.000167	CcSEcCtD
Sertraline—Hypersensitivity—Doxorubicin—pancreatic cancer	4.93e-05	0.000167	CcSEcCtD
Sertraline—Asthenia—Doxorubicin—pancreatic cancer	4.8e-05	0.000162	CcSEcCtD
Sertraline—Dizziness—Epirubicin—pancreatic cancer	4.79e-05	0.000162	CcSEcCtD
Sertraline—Pruritus—Doxorubicin—pancreatic cancer	4.74e-05	0.00016	CcSEcCtD
Sertraline—Vomiting—Epirubicin—pancreatic cancer	4.6e-05	0.000155	CcSEcCtD
Sertraline—Diarrhoea—Doxorubicin—pancreatic cancer	4.58e-05	0.000155	CcSEcCtD
Sertraline—Rash—Epirubicin—pancreatic cancer	4.56e-05	0.000154	CcSEcCtD
Sertraline—Dermatitis—Epirubicin—pancreatic cancer	4.56e-05	0.000154	CcSEcCtD
Sertraline—Headache—Epirubicin—pancreatic cancer	4.53e-05	0.000153	CcSEcCtD
Sertraline—Dizziness—Doxorubicin—pancreatic cancer	4.43e-05	0.00015	CcSEcCtD
Sertraline—Nausea—Epirubicin—pancreatic cancer	4.3e-05	0.000145	CcSEcCtD
Sertraline—Vomiting—Doxorubicin—pancreatic cancer	4.26e-05	0.000144	CcSEcCtD
Sertraline—Rash—Doxorubicin—pancreatic cancer	4.22e-05	0.000143	CcSEcCtD
Sertraline—Dermatitis—Doxorubicin—pancreatic cancer	4.22e-05	0.000142	CcSEcCtD
Sertraline—Headache—Doxorubicin—pancreatic cancer	4.19e-05	0.000142	CcSEcCtD
Sertraline—Nausea—Doxorubicin—pancreatic cancer	3.98e-05	0.000134	CcSEcCtD
